metyrapone has been researched along with Fetal Growth Retardation in 5 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Fetal Growth Retardation: Failure of a FETUS to attain expected GROWTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To control hypercortisolism, the patient was treated with metyrapone." | 6.41 | Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. ( Dokoupilová, M; Hána, V; Marek, J; Plavka, R, 2001) |
| "To control hypercortisolism, the patient was treated with metyrapone." | 2.41 | Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. ( Dokoupilová, M; Hána, V; Marek, J; Plavka, R, 2001) |
| "Maternal food restriction (MFR) causes intrauterine growth restriction, a known risk factor for developing chronic lung disease." | 1.42 | Metyrapone alleviates deleterious effects of maternal food restriction on lung development and growth of rat offspring. ( Khorram, O; Li, Y; Paek, DS; Rehan, VK; Sakurai, R; Saraswat, A; Torday, JS, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, TD | 1 |
| Sakurai, R | 2 |
| Gong, M | 1 |
| Khorram, O | 2 |
| Rehan, VK | 2 |
| Paek, DS | 1 |
| Saraswat, A | 1 |
| Li, Y | 1 |
| Torday, JS | 1 |
| Smith, JT | 1 |
| Waddell, BJ | 1 |
| Hána, V | 1 |
| Dokoupilová, M | 1 |
| Marek, J | 1 |
| Plavka, R | 1 |
| Blondeau, B | 1 |
| Lesage, J | 1 |
| Czernichow, P | 1 |
| Dupouy, JP | 1 |
| Bréant, B | 1 |
1 review available for metyrapone and Fetal Growth Retardation
| Article | Year |
|---|---|
Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.
Topics: Abortion, Therapeutic; Adolescent; Adrenal Glands; Cesarean Section; Cushing Syndrome; Female; Fetal | 2001 |
4 other studies available for metyrapone and Fetal Growth Retardation
| Article | Year |
|---|---|
Role of miR-29 in mediating offspring lung phenotype in a rodent model of intrauterine growth restriction.
Topics: Animals; Extracellular Matrix Proteins; Female; Fetal Growth Retardation; Glucocorticoids; Lung; Mal | 2018 |
Metyrapone alleviates deleterious effects of maternal food restriction on lung development and growth of rat offspring.
Topics: Age Factors; Animals; Bronchopulmonary Dysplasia; Caloric Restriction; Cell Differentiation; Cells, | 2015 |
Leptin receptor expression in the rat placenta: changes in ob-ra, ob-rb, and ob-re with gestational age and suppression by glucocorticoids.
Topics: Animals; Carbenoxolone; Dexamethasone; Enzyme Inhibitors; Female; Fetal Growth Retardation; Gene Exp | 2002 |
Glucocorticoids impair fetal beta-cell development in rats.
Topics: Adrenal Glands; Adrenalectomy; Animals; Corticosterone; Female; Fetal Blood; Fetal Growth Retardatio | 2001 |